63304-679 : Seconal Sodium 100 mg Oral Capsule


NDC: 63304-679
Labeler: Ranbaxy Pharmaceuticals Inc.
Drug Name:  Seconal Sodium
Rev. Date: 
CSA Schedule: CII (US) [1]


[1] Schedule II / IIN Controlled Substance: High potential for abuse which may lead to severe psychological or physical dependence. (i.e. Narcotics such as Dilaudid, Methadone, Demerol, Oxycodone, Percocet, Fentanyl, Morphine, Opium, Codeine, and Hydrocodone ... Schedule IIN stimulants include non-narcotic Amphetamines such as Dexedrine, Adderall, Desoxyn, Methylphenidate (Ritalin) ... Other Schedule II substances include Amobarbital, Glutethimide, and Pentobarbital. More Details: US Dept of Justice Controlled Substance Schedules.

Appearance:


Markings: RX679
Shapes:  Capsule
Colors:  Orange
Size (mm): 20
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

Active Ingredients:

  • Secobarbital

Inactive Ingredients:

  • Dimethicone
  • Fd&c Red No. 3
  • Fd&c Yellow No. 10
  • Gelatin
  • Magnesium Stearate
  • Pregelatinized Starch
  • Titanium Dioxide

Related Products:

Based on records with the same trade name.
  • 0187-4220 Seconal Sodium 100 mg Oral Capsule by Valeant Pharmaceuticals North America LLC
  • 42998-679 Seconal Sodium 100 mg Oral Capsule by Marathon Pharmaceuticals, LLC

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 63304-679 QR Code

< Prev: 63304-657Next: 63304-683 >

Related Discussions:

obtaining secobarbital
TO WHOM IT MAY CONCERN, I HAVE TRIED JUST ABOUT EVERY KIND OF SLEEPING MED... I HAVE BEEN GETTING MY MEDS ONLINE FOR 6 Y... 1 reply




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.